Indeed, Stat1-null animals show reduced macrophage infiltration [58], and in agreement with our findings, breast cancer microarray analyses indicate that high mRNA expression levels of Stat1 and its target genes belonging to the interferon-mediated signalling correlate with poor drug response and infiltration of immune cells, in particular TAMs [59]. The gene discussed is STAT1; the disease is breast cancer.